PANDION THERAPEUTICS, INC. Operating Expenses
PANDION THERAPEUTICS, INC. reported Operating Expenses of $46.71 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. operating expenses for the quarter ending 2020-12-31 was $13.42M, a 137.73% increase year-over-year.
- PANDION THERAPEUTICS, INC. operating expenses for the quarter ending 2020-09-30 was $13.62M, a 130.57% increase year-over-year.
- PANDION THERAPEUTICS, INC. operating expenses for the quarter ending 2020-06-30 was $11.16M, a 93.23% increase year-over-year.
- PANDION THERAPEUTICS, INC. operating expenses for the quarter ending 2020-03-31 was $8.51M.
- PANDION THERAPEUTICS, INC. operating expenses for fiscal 2020 was $46.71M, a 101.45% increase from fiscal 2019.
- PANDION THERAPEUTICS, INC. operating expenses for fiscal 2019 was $23.19M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-12-31 | $13.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $27.04M derived: sum of 2 quarters · filed 2021-03-12 | $38.20M derived: sum of 3 quarters · filed 2021-03-12 | $46.71M 10-K · filed 2021-03-12 |
| 2020-09-30 | $13.62M 10-Q · filed 2020-11-16 | $24.78M derived: sum of 2 quarters · filed 2020-11-16 | $33.29M 10-Q · filed 2020-11-16 | $38.93M derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-06-30 | $11.16M 10-Q · filed 2020-08-31 | $19.66M 10-Q · filed 2020-08-31 | $25.31M derived: sum of 3 quarters · filed 2021-03-12 | $31.22M derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-03-31 | $8.51M derived: 10-K 12 month − 3 quarters · filed 2021-03-12 | $14.15M derived: sum of 2 quarters · filed 2021-03-12 | $20.06M derived: sum of 3 quarters · filed 2021-03-12 | $25.84M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-12-31 | $5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $11.55M derived: sum of 2 quarters · filed 2021-03-12 | $17.33M derived: sum of 3 quarters · filed 2021-03-12 | $23.19M 10-K · filed 2021-03-12 |
| 2019-09-30 | $5.91M 10-Q · filed 2020-11-16 | $11.68M derived: sum of 2 quarters · filed 2020-11-16 | $17.54M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $5.77M 10-Q · filed 2020-08-31 | $11.63M 10-Q · filed 2020-08-31 |